PubMed

How hyperglycemia promotes atherosclerosis: molecular mechanisms.

Aronson D, Rayfield EJ.

Cardiovasc Diabetol. 2002 Apr 8;1:1.PMID: 12119059 [PubMed]Related articlesFree article

Hyperglycemia and the pathobiology of diabetic complications.

Aronson D.

Adv Cardiol. 2008;45:1-16. Review.PMID: 18230953 [PubMed - indexed for MEDLINE]Related articles

Endothelial dysfunction in normal and abnormal glucose metabolism.

Esper RJ, Vilariño JO, Machado RA, Paragano A.

Adv Cardiol. 2008;45:17-43. Review.PMID: 18230954 [PubMed - indexed for MEDLINE]Related articles

The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.

Rudijanto A.

Acta Med Indones. 2007 Jan-Mar;39(1):36-43. Review.PMID: 17939209 [PubMed - indexed for MEDLINE]Related articles

Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis.

Nakagami H, Kaneda Y, Ogihara T, Morishita R.

Curr Diabetes Rev. 2005 Feb;1(1):59-63. Review.PMID: 18220582 [PubMed - indexed for MEDLINE]Related articles

The role of protein kinase C activation and the vascular complications of diabetes.

Das Evcimen N, King GL.

Pharmacol Res. 2007 Jun;55(6):498-510. Epub 2007 May 5. Review.PMID: 17574431 [PubMed - indexed for MEDLINE]Related articles

Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.

Renier G, Mamputu JC, Serri O.

Metabolism. 2003 Aug;52(8 Suppl 1):13-8. Review.PMID: 12939734 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

Basta G, Schmidt AM, De Caterina R.

Cardiovasc Res. 2004 Sep 1;63(4):582-92. Review.PMID: 15306213 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide.

Mamputu JC, Renier G.

J Diabetes Complications. 2002 Jul-Aug;16(4):284-93.PMID: 12126787 [PubMed - indexed for MEDLINE]Related articles

Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis: Role of vitamin E.

Kartal Ozer N, Negis Y, Aytan N.

Biofactors. 2003;19(1-2):63-70.PMID: 14757978 [PubMed - indexed for MEDLINE]Related articles

Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.

Osawa T, Kato Y.

Ann N Y Acad Sci. 2005 Jun;1043:440-51. Review.PMID: 16037265 [PubMed - indexed for MEDLINE]Related articles

Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.

Li L, Sawamura T, Renier G.

Circ Res. 2004 Apr 16;94(7):892-901. Epub 2004 Mar 4.PMID: 15001526 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of protein kinase C activation in diabetic nephropathy.

Noh H, King GL.

Kidney Int Suppl. 2007 Aug;(106):S49-53. Review.PMID: 17653211 [PubMed - indexed for MEDLINE]Related articles

[Mechanism of diabetic macroangiopathy]

Nishio Y.

Nippon Rinsho. 2006 Nov;64(11):1991-7. Review. Japanese. PMID: 17087288 [PubMed - indexed for MEDLINE]Related articles

Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Woodman RJ, Chew GT, Watts GF.

Drugs. 2005;65(1):31-74. Review.PMID: 15610050 [PubMed - indexed for MEDLINE]Related articles

Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.

Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.

Eur J Pharmacol. 2005 Mar 21;511(1):53-64.PMID: 15777779 [PubMed - indexed for MEDLINE]Related articles

[The role of nonenzymatic glycation and glyco-oxidation in the development of diabetic vascular complications]

Jakus V.

Cesk Fysiol. 2003 May;52(2):51-65. Review. Slovak. PMID: 12827898 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.

Hodgkinson CP, Laxton RC, Patel K, Ye S.

Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2275-81. Epub 2008 Sep 25.PMID: 18818414 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.

Hans CP, Zerfaoui M, Naura AS, Catling A, Boulares AH.

Cardiovasc Res. 2008 Jun 1;78(3):429-39. Epub 2008 Jan 31.PMID: 18245064 [PubMed - indexed for MEDLINE]Related articlesFree article

[AGE-RAGE: a hypothesis or a mechanism?]

Isermann B, Bierhaus A, Humpert PM, Rudofsky G, Chavakis T, Ritzel R, Wendt T, Morcos M, Kasperk C, Hamann A, Nawroth PP.

Herz. 2004 Aug;29(5):504-9. Review. German. PMID: 15340736 [PubMed - indexed for MEDLINE]Related articles